MX2012007232A - Composicion nutricional alta en proteinas, baja en calorias, para la estimulacion de sistesis de proteina muscular. - Google Patents

Composicion nutricional alta en proteinas, baja en calorias, para la estimulacion de sistesis de proteina muscular.

Info

Publication number
MX2012007232A
MX2012007232A MX2012007232A MX2012007232A MX2012007232A MX 2012007232 A MX2012007232 A MX 2012007232A MX 2012007232 A MX2012007232 A MX 2012007232A MX 2012007232 A MX2012007232 A MX 2012007232A MX 2012007232 A MX2012007232 A MX 2012007232A
Authority
MX
Mexico
Prior art keywords
protein
nutritional composition
mammal
low
stimulation
Prior art date
Application number
MX2012007232A
Other languages
English (en)
Other versions
MX344088B (es
Inventor
George Verlaan
Yvette Charlotte Luiking
Marion Jourdan
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67844720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012007232(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of MX2012007232A publication Critical patent/MX2012007232A/es
Publication of MX344088B publication Critical patent/MX344088B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere al uso de Una composición nutricional alta en proteínas, baja en calorías, para el uso en la prevención o el tratamiento de un trastorno o condición en un mamífero, que involucra la declinación muscular, así como a las composiciones nutricionales altas en proteínas, bajas en calorías, específicas, para estimular la síntesis de proteína muscular en un mamífero. En particular, la invención se refiere al uso de una composición nutricional que comprende por 100 kcal: (i) al menos aproximadamente 12 g de material proteico que comprende al menos aproximadamente 8O en peso de proteína de suero de leche, con relación a la materia proteica total, y que comprende al menos aproximadamente 11% en peso de leucina, con relación al material proteico total, del cual al menos aproximadamente 20 en peso está en una forma libre, con relación a la leucina total, (ii) una fuente de grasa y una fuente de carbohidratos digeribles, para la prevención o el tratamiento de un trastorno o condición que involucra declinación muscular en un mamífero, especialmente un mamífero de edad avanzada, en donde la composición nutricional es administrada como 1 a 2 porciones diarias, cada porción que comprende entre 80 y 200 kcal.
MX2012007232A 2009-12-24 2010-12-23 Composicion nutricional alta en proteinas, baja en calorias, para la estimulacion de sistesis de proteina muscular. MX344088B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2009000508 2009-12-24
PCT/NL2009/050806 WO2011078654A1 (en) 2009-12-24 2009-12-24 Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
PCT/NL2010/050887 WO2011078677A2 (en) 2009-12-24 2010-12-23 Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis

Publications (2)

Publication Number Publication Date
MX2012007232A true MX2012007232A (es) 2012-07-30
MX344088B MX344088B (es) 2016-12-05

Family

ID=67844720

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012007232A MX344088B (es) 2009-12-24 2010-12-23 Composicion nutricional alta en proteinas, baja en calorias, para la estimulacion de sistesis de proteina muscular.

Country Status (13)

Country Link
US (1) US8846759B2 (es)
EP (2) EP2515920B1 (es)
JP (1) JP5830030B2 (es)
CN (1) CN102665736B (es)
AU (1) AU2010335044B2 (es)
BR (1) BR112012015753B1 (es)
ES (2) ES2660312T3 (es)
LT (1) LT2865382T (es)
MX (1) MX344088B (es)
PL (2) PL2865382T3 (es)
RU (1) RU2551089C2 (es)
TR (1) TR201802154T4 (es)
WO (2) WO2011078654A1 (es)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010002242A1 (en) 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
WO2011078654A1 (en) 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
WO2012091542A1 (en) * 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
EP2583565A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for enhancing energy expenditure and satiety
EP2583563A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Whey protein micelles against muscle atrophy and sarcopenia
PL2583566T3 (pl) * 2011-10-21 2016-01-29 Nestec Sa Micele serwatkowego białka do zwiększania masy mięśni i sprawności
WO2013148330A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
WO2013148329A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Charged nutritive proteins and methods
JP2015519878A (ja) 2012-03-26 2015-07-16 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養断片、タンパク質、および方法
JP2015518470A (ja) * 2012-03-26 2015-07-02 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養タンパク質および方法
GB201210100D0 (en) * 2012-06-08 2012-07-25 Whey Forward Health Ind Ltd Nutraceutical pharmaceutical composition
US9579347B2 (en) * 2012-10-04 2017-02-28 Abbott Laboratories Methods for enhancing the effect of EGCg on mitigating skeletal muscle loss
WO2014134225A2 (en) * 2013-02-26 2014-09-04 Pronutria, Inc. Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance
US9597367B2 (en) * 2013-04-19 2017-03-21 Bioventures, Llc Methods for improving muscle and heart function
WO2014191856A1 (en) * 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis
CA2914811C (en) * 2013-06-10 2020-10-27 N.V. Nutricia Muscle preservation in overweight or obese adult during weight loss program
WO2014209791A1 (en) * 2013-06-28 2014-12-31 Nestec Sa Compositions and methods for enhancing exercise performance
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
CN103766696B (zh) * 2013-12-26 2015-08-26 北京康比特体育科技股份有限公司 一种具有增肌功能的组合物及其制备方法
ES2727660T3 (es) * 2014-11-19 2019-10-17 Nestle Sa Uso de complejos de micelas de proteína de suero y pectina para controlar el peso corporal
WO2017069611A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Nutritional product for decreasing phenylalanine levels in pku patients
US10188135B2 (en) * 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
JP6948103B2 (ja) * 2016-04-14 2021-10-13 株式会社明治 フレイル改善用組み合わせ物
BR112018073930B1 (pt) * 2016-06-10 2022-08-30 Société des Produits Nestlé S.A. Composições enterais com alto teor de proteína esterilizada por calor contendo proteína de soro de leite que compreende micelas de proteína de soro de leite e uma fonte de caseína, seu processo de preparação, e usos de uma fonte de proteína e de micelas de proteína de soro de leite em combinação com uma fonte de caseína
EP3468389A1 (en) * 2016-06-10 2019-04-17 Nestec S.A. Heat sterilized high protein enteral compositions with whey protein which comprises whey protein micelles and a source of casein
CN109688842A (zh) * 2016-08-08 2019-04-26 株式会社明治 酸性液状营养组合物
CN109982585B (zh) * 2016-11-16 2024-03-15 费森尤斯卡比德国有限公司 用于患有肌少症和/或衰弱症的患者或肌少症前期和/或衰弱症前期患者的疗法中的用途的营养组合物
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2018200736A2 (en) * 2017-04-25 2018-11-01 The Buck Institute For Research On Aging Formulations for extending lifespan and healthspan
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
CH714189A1 (de) * 2017-09-25 2019-03-29 Omanda Ag Verfahren zur Herstellung von L-Leucin und Molkenprotein L-Leucin zur Nahrungsanreicherung und dessen Anwendung.
KR102775380B1 (ko) * 2017-11-02 2025-03-04 바이오벤처스, 엘엘씨 개선된 근육 단백질 합성을 위한 아미노산 보충물의 이용
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US20200384064A1 (en) * 2017-12-20 2020-12-10 Societe Des Produits Nestle S.A. Compositions and methods using high protein for induction of autophagy
CN111479580B (zh) * 2017-12-20 2024-08-06 雀巢产品有限公司 采用自噬诱发剂和高蛋白质的组合来诱发自噬的组合物和方法
WO2019190306A1 (en) * 2018-03-27 2019-10-03 N.V. Nutricia Insulin control in overweight or obese adult during life time intervention
US11026991B2 (en) * 2018-04-18 2021-06-08 Ingenious Ingredients, LP Compositions and methods of use thereof to promote muscle growth and function
CN110558569B (zh) * 2018-06-05 2024-03-12 费森尤斯卡比德国有限公司 包含酸性乳清衍生蛋白质的透明液体营养组合物
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
CN109077302A (zh) * 2018-07-18 2018-12-25 辰欣药业股份有限公司 一种治疗和预防老年肌肉衰减综合症的医用食品及其制备方法
JP7044306B2 (ja) * 2018-07-31 2022-03-30 ユーハ味覚糖株式会社 ロイシン血中濃度上昇促進剤及びその用途
CN109198520A (zh) * 2018-10-13 2019-01-15 赤峰禾士营养食品科技有限公司 一种具有增肌功能的复合型营养健肌粉及其制备方法
EP4696147A3 (en) 2018-11-20 2026-04-22 Fonterra Co-Operative Group Ltd Dairy product and process
CN111248289B (zh) * 2018-11-30 2023-04-07 内蒙古伊利实业集团股份有限公司 一种组合物、其制备方法及用途
WO2020118196A1 (en) * 2018-12-06 2020-06-11 Nutrient Foods, Llc Edible high nutrient density composite and the use for reduction and management of human hypertension
JP2020150805A (ja) * 2019-03-18 2020-09-24 株式会社０ タンパク質高含有アイスクリーム
CH715997A1 (de) * 2019-03-25 2020-09-30 Omanda Ag Proteingetränk und Darreichungseinheit zur Verabreichung von mit L-Leucin-angereicherten Molkenproteinkomponenten als Nahrungsanreicherung und dessen Herstellung.
AU2020284169B2 (en) * 2019-05-31 2026-03-05 Societe Des Produits Nestle Sa MCT-based nutrition blend for providing health benefits in animals
MA56126A (fr) 2019-06-07 2022-04-13 Whitewave Services Inc Mélanges de protéines à base de plantes et compositions nutritionnelles
BR112021022519A2 (pt) * 2019-06-20 2021-12-28 Nestle Sa Composições e métodos que usam timol e/ou carvacrol para indução de autofagia
WO2021198400A1 (en) * 2020-04-01 2021-10-07 Société des Produits Nestlé S.A. Compositions containing amino acids and methods of using such compositions for treating sarcopenia
US20240138458A1 (en) * 2020-08-14 2024-05-02 Seoul National University Hospital Protein food composition having ultra-low calories and high bioabsorption rate and method for providing diet information using same
EP4307923B1 (en) * 2021-03-17 2025-06-25 N.V. Nutricia Liquid nutritional composition suitable for muscle function
CN115474688A (zh) * 2021-06-16 2022-12-16 法尔玛国际健康管理有限公司 一种提升免疫力和增加肌肉的营养组合物
CN113412936A (zh) * 2021-07-14 2021-09-21 复旦大学附属中山医院 一种肌少症患者的肠内营养制剂
CN115886076B (zh) * 2022-11-26 2024-04-19 黑龙江飞鹤乳业有限公司 含亮氨酸类蛋白反应产物的组合物及在抗肌肉衰减的应用
GB2628186A (en) * 2023-03-17 2024-09-18 Mjn Us Holdings Llc Gender-specific compositions
WO2024216228A2 (en) * 2023-04-14 2024-10-17 Vitakey Inc. Compositions and methods of controlling mammalian satiety
WO2026093457A1 (en) * 2024-10-31 2026-05-07 Société des Produits Nestlé S.A. Low lactose, low sugar, milk-based composition comprising gos for use in improving muscle growth, function and/or mass

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888552A (en) 1988-04-29 1999-03-30 Immunotec Research Corporation Ltd. Anti-cancer therapeutic compositions containing whey protein concentrate
DE69804850T2 (de) 1997-12-11 2002-08-22 Arla Foods Amba, Viby J Verfahren zur herstellung eines kappa-casein-glykomakropeptides oder eines abkoemmlings davon
DE10006989A1 (de) 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
RU2335927C2 (ru) * 2002-09-20 2008-10-20 Новартис Аг Обогащенные лейцином питательные композиции
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
ES2781848T3 (es) 2003-10-24 2020-09-08 Nutricia Nv Oligosacáridos inmunomoduladores
EP1865944B1 (en) 2005-03-29 2018-08-29 Ajinomoto Co., Inc. Amino acid-containing composition used for preventing or remedying decrease in skeletal muscle mass of aged people, comprising L-leucine
PL1916913T3 (pl) 2005-08-23 2011-04-29 Armand Herberger Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
PL1983849T3 (pl) 2006-01-20 2013-09-30 Innova Food Ab Kompozycja spożywcza zawierająca aminokwasy
US20070248648A1 (en) 2006-04-20 2007-10-25 Next Proteins, Inc. High protein, fatigue reducing powder
US20070280997A1 (en) * 2006-05-31 2007-12-06 Pacifichealth Laboratories, Inc. Composition for enhancing muscle recovery
US20090042770A1 (en) 2007-01-14 2009-02-12 Bastian Eric D Branched Chain Amino Acid Chelate
WO2008086538A1 (en) 2007-01-14 2008-07-17 Glanbia Plc Branched chain amino acid chelate
WO2009113845A1 (en) 2008-03-12 2009-09-17 N.V. Nutricia High protein liquid enteral nutritional composition
WO2011078654A1 (en) 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis

Also Published As

Publication number Publication date
US20130203658A1 (en) 2013-08-08
ES2528405T3 (es) 2015-02-10
ES2660312T3 (es) 2018-03-21
LT2865382T (lt) 2018-04-10
EP2515920A2 (en) 2012-10-31
US8846759B2 (en) 2014-09-30
PL2865382T3 (pl) 2018-06-29
AU2010335044A1 (en) 2012-07-26
EP2865382B1 (en) 2018-01-17
RU2551089C2 (ru) 2015-05-20
JP2013515718A (ja) 2013-05-09
CN102665736A (zh) 2012-09-12
JP5830030B2 (ja) 2015-12-09
WO2011078677A2 (en) 2011-06-30
RU2012131518A (ru) 2014-01-27
BR112012015753A2 (pt) 2016-05-17
AU2010335044B2 (en) 2015-11-19
EP2865382A1 (en) 2015-04-29
TR201802154T4 (tr) 2018-03-21
EP2515920B1 (en) 2014-12-17
PL2515920T3 (pl) 2015-04-30
CN102665736B (zh) 2014-10-29
WO2011078677A3 (en) 2011-09-09
BR112012015753B1 (pt) 2019-11-26
WO2011078654A1 (en) 2011-06-30
MX344088B (es) 2016-12-05

Similar Documents

Publication Publication Date Title
MX344088B (es) Composicion nutricional alta en proteinas, baja en calorias, para la estimulacion de sistesis de proteina muscular.
EP3335710A3 (en) Use of nutritional compositions for preventing disorders
MY176679A (en) Use of nutritional compositions for preventing disorders
RU2007102702A (ru) Композиции, пригодные для лечения кожных признаков старения
DE202012011540U1 (de) Nahrungsmittelzusammensetzung mit Aminosäuren und Kakao
CN111315239A (zh) 针对肌肉质量和/或肌肉量使用橄榄苦苷或姜黄素的组合物和方法
MY145662A (en) Nutrition for obese patients
WO2011096413A1 (ja) 運動機能改善剤
WO2010146078A3 (en) Novel uses of hydroxyproline compositions
PH12013500916A1 (en) Method for inhibiting pathogens using a nutritional composition
Volkert et al. Protein requirements in the elderly
JP5980519B2 (ja) Ａｍｐｋ活性化剤
Parate Vishal et al. Food fortification of soy protein isolate for human health
Jana et al. Role of whey proteins in combating geriatric disorders.
JP6716330B2 (ja) ウロプラキン発現促進剤
BR112019005785A2 (pt) métodos que reduzem os desejos alimentares, pro-movem perda de peso e/ou tratam sobrepeso ou obesidade
MX2013011144A (es) Inhibidores de trmp5 que ayudan a la reduccion del peso corporal sin reducir la ingesta de alimentos.
JP5394644B2 (ja) アスペルロシドまたはその類縁体を含む筋肉増強剤
CN109953347A (zh) 一种改善中老年记忆力的胶原蛋白粉
JPWO2007026820A1 (ja) Ｄ−アロースによる高血圧、心肥大発症抑制効果の利用
WO2020066484A1 (ja) エラグ酸含有組成物
JP5748441B2 (ja) シトルリンを有効成分として含有する骨量低下改善剤
CN103564576A (zh) 一种调节脾虚湿重的保健饮品
JP2011234664A (ja) 遺伝子変異型に対応したサプリメントセット及びその提供方法
Erwan et al. Effects of levels of L-leucine supplementation with sub-optimal protein in the diet of grower-finisher broiler chickens on carcass composition and sensory characteristics

Legal Events

Date Code Title Description
FG Grant or registration